logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Immuneel Therapeutics raised INR 100 Cr in an extended Series A funding round led by Taiba Middle East

Jul 10, 2024•over 1 year ago

Amount Raised

₹100

Round Type

series a

BengaluruBiotechnologyHealth Care

Investors

Taiba Middle East

Description

Biotech startup Immuneel Therapeutics has secured close to INR 100 Cr (almost $12 Mn) as a part of its extended Series A funding round from Taiba Middle East, which aims to use the funds for growth and expansion.

Company Information

Company

Immuneel Therapeutics

Location

Bengaluru, Karnataka, India

About

A pioneering clinical stage startup company leading the Cell & Gene therapy revolution and are committed to bringing breakthrough cancer treatment to patients in India, making it accessible & affordable.

Related People

2 contacts

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech